Press-release for stocks for rytm

Prices are updated after-hours

| 189.86% | O: 0.0% H: 3.41% C: 3.12%
disease obesity genetic clinical trials trial setmelanotide rare

Rhythm Pharmaceuticals to Present at the 59th Annual ESPE Meeting
Published: 2021-08-12 (Crawled : 12:00) - globenewswire.com
RYTM A | $40.0 2.54% 2.34% 410K

| 189.86% | O: 0.0% H: 3.41% C: 3.12%

77%

23%

MTTR | News 4 | $4.6 164.37% 62.17% 26M

AGBA | $2.97 137.6% 57.48% 66M

EDBL | News | $6.59 75.27% 41.8% 2M

ZAPP | $4.44 50.2% 33.12% 370K

MTC | $2.24 43.59% 30.67% 6M

OPRT | News | $3.15 40.0% 29.13% 12M

SHIM | $3.045 35.33% 26.23% 870K

HKIT | $1.33 30.39% 24.16% 390K

ABVC | $1.35 29.81% 23.53% 7.1M

OST | $0.5 25.0% 21.88% 280K

Save your searches and get alerts when important news are released.